May 2017 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2017. This roundup includes the latest...
Intra-Arterial Treatment Effective With Extracranial Carotid Disease
IAT seems to be at least as effective for patients with acute ischemic stroke, with versus without ECD
β-Blocker Use Not Linked to Reduced Mortality After AMI
No significant difference in mortality for MI patients without HF, LVSD with, without β-blocker use
Medication Adherence Up With Refill Synchronization Model
Improvement in medication-taking behavior; cost savings over one year for HTN, DM, hyperlipidemia
Excess Weight Increases Costs Across Health Care Settings
Percentage increases in costs associated with obesity were highest for medications, higher for women
Evacetrapib Appears Futile in High-Risk Vascular Disease
No reduction in primary end point events, including death from cardiovascular causes, MI, stroke
Distinct Maternal, Fetal Risks for Anticoagulants in Pregnancy
VKA, LMWH tied to lowest risk of adverse maternal, fetal outcomes, respectively
Self-Pay for Obesity Treatment Doesn’t Improve Weight Loss
Weight loss doesn't differ for employees with insurance, nonemployees who pay out of pocket
Reduced Cellular Aging Seen With Regular, Strenuous Exercise
Adults who engage in high levels of exercise may gain nine 'biological' years, researcher says
Breaking Up Sedentary Time With Upper Body Activity Beneficial
Short bouts of arm ergometry linked to reductions in mean blood glucose, insulin iAUC in obese individuals
